US Proton Therapy Outlook: Market Opportunities
In the face of an alarmingly rising incidences of cancer and limited treatment options, physicians are being forced to look for treatments beyond the conventional ones. In such a scenario, Proton Therapy, the most advanced radiation technique available, is being projected as the Rolls Royce of Radiation Oncology. Unfortunately, access to proton therapy is limited for many patients due to the low number of proton therapy centers. Hence, many research institutes and hospitals are now investing in proton therapy to make it more accessible to patients.
According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers by 2018, a number which is double the current figure. Consequently, the market will breach the Billion dollar mark to attain revenue of around US$ 1.2 Billion by 2018. The following 70 pages report provides an insight into the cancer demographics of US and the various possible causes for a high incidence there. The document covers the historical trend (2008-2013) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.
Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country etc, we have performed an opportunity assessment for the potential of proton therapy in US. We have been able to draw the current and future demand of number of proton therapy centers in US. Not only this, the report also enlists the top ten states with the maximum potential for a proton therapy center. The list provides an insight into the current and future scenarios of centers along with an estimation of shortage of proton centers in each state which can help service providers and vendors to extract benefits from the largely untapped but lucrative market.
As for the market, the report provides the state-wide distribution of proton therapy centers in US. A thorough analysis has been done on the existing and upcoming proton therapy centers to measure the market size and its future condition.
After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2018 for service providers and equipment vendors. There is also a ‘strengths-weakness’ analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in US till 2018, thus making it a must read for consultants and companies planning to enter the market.
According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers by 2018, a number which is double the current figure. Consequently, the market will breach the Billion dollar mark to attain revenue of around US$ 1.2 Billion by 2018. The following 70 pages report provides an insight into the cancer demographics of US and the various possible causes for a high incidence there. The document covers the historical trend (2008-2013) of cancer incidences, deaths and prevalence along with state-wide and site-wide cancer incidences in the country.
Based on a complex correlation-regression model accounting population demographics, disease statistics, macro & micro economic indicators of the country etc, we have performed an opportunity assessment for the potential of proton therapy in US. We have been able to draw the current and future demand of number of proton therapy centers in US. Not only this, the report also enlists the top ten states with the maximum potential for a proton therapy center. The list provides an insight into the current and future scenarios of centers along with an estimation of shortage of proton centers in each state which can help service providers and vendors to extract benefits from the largely untapped but lucrative market.
As for the market, the report provides the state-wide distribution of proton therapy centers in US. A thorough analysis has been done on the existing and upcoming proton therapy centers to measure the market size and its future condition.
After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand of the market and its probable transformation by 2018 for service providers and equipment vendors. There is also a ‘strengths-weakness’ analysis of equipment vendors along with their business overviews, products & services, and existing & planned installations in US till 2018, thus making it a must read for consultants and companies planning to enter the market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. US CANCER DEMOGRAPHICS
3.1 Incidence by State
3.2 Incidence by Site
4. CURRENT RADIATION THERAPIES
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Proton Therapy
4.6.1 Why Proton Therapy?
5. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource
6. US PROTON THERAPY MARKET OUTLOOK TO 2018
6.1 Current Market Size and Future Growth
6.2 Potential Patients by State (2013 & 2018)
6.2.1 Market Penetration
6.3 Analysis of Existing and Forthcoming Players
6.3.1 Service Providers
6.3.2 Equipment Providers
6.4 Opportunity Assessment
6.5 Market Trends
6.5.1 Number of Treatment Rooms
6.5.2 Type of Proton Accelerator
7. REIMBURSEMENT SCENARIO
8. INDUSTRY DRIVERS AND RESTRAINTS
8.1 Drivers
8.2 Restraints
9. COMPETITIVE LANDSCAPE AND STRATEGIC ANALYSIS
9.1 IBA
9.2 Hitachi
9.3 Mevion Medical Systems
9.4 Varian
2. RESEARCH METHODOLOGY
3. US CANCER DEMOGRAPHICS
3.1 Incidence by State
3.2 Incidence by Site
4. CURRENT RADIATION THERAPIES
4.1 Third Dimensional Conformal Therapy (CRT)
4.2 Image Guided Radiotherapy (IGRT)
4.3 Intensity Modulated Radiotherapy (IMRT)
4.4 Stereotactic Radiotherapy
4.5 Neutron Therapy
4.6 Proton Therapy
4.6.1 Why Proton Therapy?
5. COMPONENTS OF A STANDARD PROTON THERAPY CENTER
5.1 Proton Accelerator
5.2 Beam Transport System
5.3 Beam Delivery System
5.4 Nozzle
5.4.1 Single Scattering
5.4.2 Double Scattering
5.4.3 Uniform Scanning Nozzle
5.4.4 Pencil Scanning Nozzle
5.5 Treatment Planning System
5.6 Image Viewers
5.7 Patient Positioning System
5.8 Human Resource
6. US PROTON THERAPY MARKET OUTLOOK TO 2018
6.1 Current Market Size and Future Growth
6.2 Potential Patients by State (2013 & 2018)
6.2.1 Market Penetration
6.3 Analysis of Existing and Forthcoming Players
6.3.1 Service Providers
6.3.2 Equipment Providers
6.4 Opportunity Assessment
6.5 Market Trends
6.5.1 Number of Treatment Rooms
6.5.2 Type of Proton Accelerator
7. REIMBURSEMENT SCENARIO
8. INDUSTRY DRIVERS AND RESTRAINTS
8.1 Drivers
8.2 Restraints
9. COMPETITIVE LANDSCAPE AND STRATEGIC ANALYSIS
9.1 IBA
9.2 Hitachi
9.3 Mevion Medical Systems
9.4 Varian
LIST OF FIGURES
Figure 3-1: Cancer Incidence (Million), 2008-2013
Figure 3-2: Cancer Mortality (‘000), 2008-2013
Figure 3-3: Cancer Prevalence (Million), 2008-2013
Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2013-2018
Figure 6-2: Share of Proton Therapy Market in Potential Market (2013)
Figure 6-3: Share of Proton Therapy Market in Potential Market (2018)
Figure 6-4: Market Share of Service Providers (2013)
Figure 6-5: Market Share of Service Providers (2018)
Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2013)
Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2018)
Figure 6-8: Demand of Proton Therapy Centers (2013 & 2018)
Figure 6-9: Shortage of Proton Therapy Centers (2013 & 2018)
Figure 6-10: Proton Therapy Center by Number of Treatment Rooms (2013 & 2018)
Figure 6-11: Proton Therapy Center by Type of Proton Accelerator (2013 & 2018)
Figure 9-1: IBA: Breakdown of Revenue by Activity (2013)
Figure 3-1: Cancer Incidence (Million), 2008-2013
Figure 3-2: Cancer Mortality (‘000), 2008-2013
Figure 3-3: Cancer Prevalence (Million), 2008-2013
Figure 4-1: Advantages of Proton Therapy over Conventional Radiation Therapy
Figure 5-1: Components of a Proton Therapy Center
Figure 6-1: Proton Therapy Market (Million US$), 2013-2018
Figure 6-2: Share of Proton Therapy Market in Potential Market (2013)
Figure 6-3: Share of Proton Therapy Market in Potential Market (2018)
Figure 6-4: Market Share of Service Providers (2013)
Figure 6-5: Market Share of Service Providers (2018)
Figure 6-6: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2013)
Figure 6-7: Share of Vendors by Number of Proton Accelerators Installed in US Proton Therapy Centers (2018)
Figure 6-8: Demand of Proton Therapy Centers (2013 & 2018)
Figure 6-9: Shortage of Proton Therapy Centers (2013 & 2018)
Figure 6-10: Proton Therapy Center by Number of Treatment Rooms (2013 & 2018)
Figure 6-11: Proton Therapy Center by Type of Proton Accelerator (2013 & 2018)
Figure 9-1: IBA: Breakdown of Revenue by Activity (2013)
LIST OF TABLES
Table 3-1: Cancer Incidence by State (Million), 2008-2013
Table 3-2: Cancer Incidence by Site (Million), 2008-2013
Table 6-1: State-wide Potential Patients for Proton Therapy (2013)
Table 6-2: State-wide Potential Patients for Proton Therapy (2018)
Table 6-3: Proton Therapy Centers (2013)
Table 6-4: Upcoming Proton Therapy Centers (2014 to 2018)
Table 6-5: Proton Therapy Equipment Providers with number of Installations till 2013
Table 6-6: Proton Therapy Equipment Providers with Number of Installations by 2018
Table 6-7: Shortage of Proton Therapy Centers (2018)
Table 9-1: IBA - Proton Therapy Products and Services
Table 9-2: IBA - Key Financials (Million Euro), 2011-2013
Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
Table 9-4: IBA - Strengths and Weaknesses
Table 9-5: Hitachi - Key Financials (Billion US$), 2011-2013
Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
Table 9-7: Hitachi - Strengths and Weaknesses
Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
Table 9-9: Mevion - Strengths and Weaknesses
Table 9-10: Varian - Proton Therapy Products and Services
Table 9-11: Varian - Key Financials (Billion US$), 2011-2013
Table 9-12: Varian: Proton Therapy Installations
Table 9-13: Varian - Strengths and Weaknesses
Table 3-1: Cancer Incidence by State (Million), 2008-2013
Table 3-2: Cancer Incidence by Site (Million), 2008-2013
Table 6-1: State-wide Potential Patients for Proton Therapy (2013)
Table 6-2: State-wide Potential Patients for Proton Therapy (2018)
Table 6-3: Proton Therapy Centers (2013)
Table 6-4: Upcoming Proton Therapy Centers (2014 to 2018)
Table 6-5: Proton Therapy Equipment Providers with number of Installations till 2013
Table 6-6: Proton Therapy Equipment Providers with Number of Installations by 2018
Table 6-7: Shortage of Proton Therapy Centers (2018)
Table 9-1: IBA - Proton Therapy Products and Services
Table 9-2: IBA - Key Financials (Million Euro), 2011-2013
Table 9-3: IBA - Existing and Upcoming Proton Therapy Installations
Table 9-4: IBA - Strengths and Weaknesses
Table 9-5: Hitachi - Key Financials (Billion US$), 2011-2013
Table 9-6: Hitachi - Existing and Upcoming Proton Therapy Installations
Table 9-7: Hitachi - Strengths and Weaknesses
Table 9-8: Mevion - Existing and Upcoming Proton Therapy Installations
Table 9-9: Mevion - Strengths and Weaknesses
Table 9-10: Varian - Proton Therapy Products and Services
Table 9-11: Varian - Key Financials (Billion US$), 2011-2013
Table 9-12: Varian: Proton Therapy Installations
Table 9-13: Varian - Strengths and Weaknesses
